These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7213509)

  • 1. Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694.
    Davies HA; Rhodes J; Thomas M
    Br J Clin Pharmacol; 1981 Jan; 11(1):53-6. PubMed ID: 7213509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of FPL 52694 on gastric acid secretion in the healthy human stomach.
    Reimann HJ; Schmidt U; Ultsch B; Sullivan TJ; Wendt P
    Gut; 1984 Nov; 25(11):1221-4. PubMed ID: 6500362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a mast cell stabiliser (FPL 52694) on human gastric secretion.
    Boyd EJ; Wilson JA; Wormsley KG; Richards MH; Langman MJ
    Agents Actions; 1985 Sep; 16(6):462-7. PubMed ID: 4072827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of gastric acid secretion in the conscious dog by the mast-cell stabilizing agent, FPL 52694.
    Canfield SP; Curwain BP
    Br J Pharmacol; 1983 Sep; 80(1):27-32. PubMed ID: 6652372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of two mast cell stabilising agents and verapamil on rat gastric acid secretion in vitro.
    Canfield P; Coruzzi G; Curwain B; Rundell T
    Eur J Pharmacol; 1985 Oct; 116(1-2):89-95. PubMed ID: 3932083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric juice electrolyte secretion in conscious dogs with gastric fistulae and its modification by FPL 52694, a mast cell stabilizing agent.
    Canfield SP; Curwain BP
    Br J Pharmacol; 1983 Nov; 80(3):451-7. PubMed ID: 6357336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of antisecretory action of intragastric FPL-52694: a mast cell stabilizer in anesthetized rats.
    Takeuchi K; Ueki S; Okabe S
    Digestion; 1986; 34(4):259-67. PubMed ID: 3743910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gastric acid secretion in conscious dog with fistula following intragastric administration of FPL 52694.
    Curwain BP; Canfield SP
    Int J Tissue React; 1983; 5(3):245-7. PubMed ID: 6654623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of FPL-52694, a new mast cell stabilizer, on gastric secretion and various acute gastric lesions in rats.
    Takeuchi K; Ishihara Y; Kunimi H; Okabe S
    Agents Actions; 1984 Jun; 14(5-6):637-42. PubMed ID: 6540973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind crossover study of the effect of a chromone carboxylic acid, FPL 52694, on overnight fasting gastric acid secretion.
    Hebnes K; Selbekk BH; Vatn MH
    Scand J Gastroenterol; 1986 Oct; 21(8):965-8. PubMed ID: 3095913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gastric acid secretion by sodium cromoglycate and FPL 52694.
    Nicol AK; Thomas M; Wilson J
    J Pharm Pharmacol; 1981 Aug; 33(8):554-6. PubMed ID: 6115937
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
    Okabe S; Shimosako K; Amagase K
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of loperamide and naloxone on gastric acid secretion in healthy man.
    Caldara R; Cambielli M; Masci E; Guslandi M; Barbieri C; Ferrari C
    Gut; 1981 Sep; 22(9):720-3. PubMed ID: 7297919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exogen pentagastrin on mastocyte degranulation, gastric cAMP and intragastric pH in Shay rats.
    Hierro JH; Sánchez-Barriga MJ; Alonso MC; Sánchez-Barriga R; de la Fuente M
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):9-12. PubMed ID: 2985892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of inhibitory action of secretin on gastric acid secretion in conscious rats.
    Shimizu K; Li P; Lee KY; Chang TM; Chey WY
    J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):501-8. PubMed ID: 8568688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.
    Jansen JB; Lundborg P; Baak LC; Greve J; Ohman M; Stöver C; Röhss K; Lamers CB
    Gut; 1988 Jan; 29(1):75-80. PubMed ID: 3343017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired gastric acid secretion in mast cell-deficient mice.
    Stechschulte DJ; Morris DC; Jilka RL; Stechschulte DJ; Dileepan KN
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G41-7. PubMed ID: 1695487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
    Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
    Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
    Lind T; Cederberg C; Ekenved G; Haglund U; Olbe L
    Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of meal stimulated gastric acid secretion by an octapeptide somatostatin analogue SMS 201-995.
    Olsen JA; Loud FB; Christiansen J
    Gut; 1987 Apr; 28(4):464-7. PubMed ID: 2884171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.